These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30623278)

  • 1. Control of hospital acquired infections and antimicrobial resistance in Europe: the way to go.
    Friedrich AW
    Wien Med Wochenschr; 2019 Feb; 169(Suppl 1):25-30. PubMed ID: 30623278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
    GBD 2021 Antimicrobial Resistance Collaborators
    Lancet; 2024 Sep; 404(10459):1199-1226. PubMed ID: 39299261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.
    Cassini A; Plachouras D; Eckmanns T; Abu Sin M; Blank HP; Ducomble T; Haller S; Harder T; Klingeberg A; Sixtensson M; Velasco E; Weiß B; Kramarz P; Monnet DL; Kretzschmar ME; Suetens C
    PLoS Med; 2016 Oct; 13(10):e1002150. PubMed ID: 27755545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Is Driving the Epidemiology of Methicillin-Resistant
    Borg MA; Camilleri L
    Microb Drug Resist; 2021 Jul; 27(7):889-894. PubMed ID: 33337277
    [No Abstract]   [Full Text] [Related]  

  • 6. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
    European Antimicrobial Resistance Collaborators
    Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.
    Cassini A; Högberg LD; Plachouras D; Quattrocchi A; Hoxha A; Simonsen GS; Colomb-Cotinat M; Kretzschmar ME; Devleesschauwer B; Cecchini M; Ouakrim DA; Oliveira TC; Struelens MJ; Suetens C; Monnet DL;
    Lancet Infect Dis; 2019 Jan; 19(1):56-66. PubMed ID: 30409683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
    Antimicrobial Resistance Collaborators
    Lancet Glob Health; 2024 Feb; 12(2):e201-e216. PubMed ID: 38134946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European intensive care physicians' experience of infections due to antibiotic-resistant bacteria.
    Lepape A; Jean A; De Waele J; Friggeri A; Savey A; Vanhems P; Gustin MP; Monnet DL; Garnacho-Montero J; Kohlenberg A
    Antimicrob Resist Infect Control; 2020; 9(1):1. PubMed ID: 31908772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between antimicrobial consumption and incidence of health-care-associated infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 2000 to 2010.
    Lai CC; Chu CC; Cheng A; Huang YT; Hsueh PR
    J Microbiol Immunol Infect; 2015 Aug; 48(4):431-6. PubMed ID: 24388582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis.
    Nellums LB; Thompson H; Holmes A; Castro-Sánchez E; Otter JA; Norredam M; Friedland JS; Hargreaves S
    Lancet Infect Dis; 2018 Jul; 18(7):796-811. PubMed ID: 29779917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-microbial coating innovations to prevent infectious diseases (AMiCI): Cost action ca15114.
    Dunne CP; Keinänen-Toivola MM; Kahru A; Teunissen B; Olmez H; Gouveia I; Melo L; Murzyn K; Modic M; Ahonen M; Askew P; Papadopoulos T; Adlhart C; Crijns FRL
    Bioengineered; 2017 Nov; 8(6):679-685. PubMed ID: 28453429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, risk factors, and antimicrobial resistance of endemic healthcare-associated infections in Africa: a systematic review and meta-analysis.
    Bunduki GK; Masoamphambe E; Fox T; Musaya J; Musicha P; Feasey N
    BMC Infect Dis; 2024 Feb; 24(1):158. PubMed ID: 38302895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of antibiotic resistance in Italy and Western Europe in 2019: a MICROBE-based comparative analysis.
    Zamagni G; Forni S; Iavicoli I; Guicciardi S; Buonsenso D; Ferrara P; De Luca M; Golinelli D; Sanmarchi F; Collatuzzo G; Gemmi F; Naghavi M; Sabbatucci M; Monasta L
    Epidemiol Prev; 2024; 48(1):48-59. PubMed ID: 38482785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe.
    Köck R; Becker K; Cookson B; van Gemert-Pijnen JE; Harbarth S; Kluytmans J; Mielke M; Peters G; Skov RL; Struelens MJ; Tacconelli E; Navarro Torné A; Witte W; Friedrich AW
    Euro Surveill; 2010 Oct; 15(41):19688. PubMed ID: 20961515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance, infection control and planning for pandemics: the importance of knowledge transfer in healthcare resilience and emergency planning.
    Cole J
    J Bus Contin Emer Plan; 2012 Autumn-2013 Winter; 6(2):122-35. PubMed ID: 23315247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Process and outcome indicators for infection control and prevention in European acute care hospitals in 2011 to 2012 - Results of the PROHIBIT study.
    Hansen S; Schwab F; Zingg W; Gastmeier P;
    Euro Surveill; 2018 May; 23(21):. PubMed ID: 29845929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.
    Polly M; de Almeida BL; Lennon RP; Cortês MF; Costa SF; Guimarães T
    Am J Infect Control; 2022 Jan; 50(1):32-38. PubMed ID: 34562526
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.